Suppr超能文献

miRNA-27a 及其信号通路 PPAR/RXRα 在甲状腺癌患者中的预后价值。

Prognostic value of the miRNA-27a and PPAR/RXRα signaling axis in patients with thyroid carcinoma.

机构信息

Department of Surgery, Tulane University, School of Medicine, New Orleans, LA 70112, USA.

Department of Histology & Cell Biology, Genetics Unit, Faculty of Medicine, Suez Canal University, Ismailia 41522, Egypt.

出版信息

Epigenomics. 2020 Oct;12(20):1825-1843. doi: 10.2217/epi-2020-0167. Epub 2020 Sep 24.

Abstract

The authors aimed to evaluate the prognostic value of miRNA-27a (miR-27a), peroxisome proliferator-activated receptor alpha/gamma () and retinoid X receptor alpha ) tissue expression in patients with thyroid carcinoma. The expression levels were quantified in 174 archived thyroid specimens using real-time quantitative PCR. Downregulation of miR-27a was associated with lymph node stage and multifocality. expression was associated with histopathological type, tumor size and lymph node invasion. Moreover, expression was lower in patients who underwent total/subtotal thyroidectomy or received radioactive iodine treatment. Patients with upregulated miR-27a and downregulated RXRα showed a higher frequency of advanced lymph node stage and relapse by cluster analysis. Both miR-27a and PPARα/RXRα showed association with different poor prognostic indices in thyroid cancer patients.

摘要

作者旨在评估微小 RNA-27a(miR-27a)、过氧化物酶体增殖物激活受体α/γ(PPARα/γ)和视黄醇 X 受体α(RXRα)组织表达在甲状腺癌患者中的预后价值。使用实时定量 PCR 定量检测了 174 例存档甲状腺标本中的表达水平。miR-27a 的下调与淋巴结分期和多灶性有关。表达与组织病理学类型、肿瘤大小和淋巴结浸润有关。此外,在接受全/次全甲状腺切除术或放射性碘治疗的患者中,表达水平较低。通过聚类分析,miR-27a 上调和 RXRα 下调的患者出现晚期淋巴结分期和复发的频率更高。miR-27a 和 PPARα/RXRα 均与甲状腺癌患者不同的不良预后指标相关。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验